1. H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial. (26th September 2015) Authors: Daniele, G.; Morabito, A.; Favaretto, A.; Filipazzi, V.; Rossi, A.; Gebbia, V.; Castiglione, F.; Cavanna, L.; Maiello, E.; Valmadre, G.; Costanzo, R.; Manzo, A.; Bonanno, L.; Piazza, E.; Maione, P.; Mancuso, G.; Di Maio, M.; Piccirillo, M.C.; Gallo, C.; Perrone, F. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗